Filmed at the 2019 STS Annual Meeting in San Diego, California, USA, Jill Ley of California Pacific Medical Center in San Francisco moderates a discussion on the ERAS multidisciplinary team.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Videos - Roundtables
August 15, 2019
Filmed at the 2019 AATS Annual Meeting in Toronto, Canada, Marc Moon of Washington University in St Louis, Missouri, moderates a discussion on wellness in cardiothoracic surgery.
August 7, 2019
Three pioneers of Enhanced Recovery After Surgery discuss why its principles can and should apply to every patient admitted for surgical treatment.
August 1, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, Mara Antonoff of the MD Anderson Cancer Center moderates a discussion on how immunotherapy is changing the landscape of surgical lung cancer care.
July 11, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, Mara Antonoff of the University of Texas MD Anderson Cancer Center moderates a discussion on building a practice early in one's career.
July 3, 2019
Filmed at the 2019 AATS Annual Meeting in Toronto, Canada, Daniel Engelman of Baystate Medical Center in Springfield, Massachusetts, USA, moderates a discussion on enhanced recovery after surgery (ERAS) for cardiac surgery guidelines for perioperative care.
June 19, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, Patrick Myers of the Lausanne University Hospital in Switzerland moderates a discussion on the usage of arterial grafts in coronary artery bypass.
June 14, 2019
Follow medical student Jackie Olive and cardiothoracic surgery resident Jessica Luc as they attend the 2019 STS Annual Meeting.
June 13, 2019
Filmed at the 2018 EACTS Annual Meeting in Milan, Italy, Mohamad Bashir of the Barts Heart Centre in London, UK, moderates a discussion on the frozen elephant trunk procedure.
June 11, 2019
Tom C. Nguyen moderates a discussion of the recently published trials on TAVR in low-risk patients with severe symptomatic aortic stenosis, focusing on the implications these studies have for surgeons.